Population Genomics Market Report 2025

The population genomics market size has grown rapidly in recent years. It will grow from $7.22 billion in 2024 to $8.25 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth during the historic period was driven by increasing investment in genomic research, expansion of genomic service providers, growth of direct to consumer genomics services, rising government funding for genomics initiatives, and development of genomic research infrastructure.

The population genomics market size is expected to see rapid growth in the next few years. It will grow to $13.84 billion in 2029 at a compound annual growth rate (CAGR) of 13.8%. The growth during the forecast period is fueled by the rising prevalence of genetic disorders, increasing incidence of cancer, growing burden of rare diseases, rising demand for personalized medicine, and greater integration of genomics into clinical diagnostics. The primary trends in the forecast period include advancements in next generation sequencing, progress in single cell genomics, integration of artificial intelligence in genomic analysis, miniaturization of sequencing platforms, and improvements in bioinformatics tools.

The increasing demand for personalized medicine is expected to drive the growth of the population genomics market. Personalized medicine involves customizing medical treatments based on an individual’s genetic makeup. This demand is growing as advancements in genomic technologies lower their cost, making targeted therapies more accessible to a wider population. Population genomics plays a critical role in personalized medicine by identifying genetic variations within specific populations, enabling healthcare providers to personalize treatments and medications for improved effectiveness and safety. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, compared to just six in 2022. As personalized medicine gains momentum, the demand for population genomics continues to rise.

Companies in the population genomics market are focusing on developing advanced tools such as ultra-high throughput library preparation kits to enhance the efficiency, accuracy, and throughput of genomic research. These kits are designed to rapidly prepare large numbers of DNA or RNA samples for sequencing in a single workflow, ensuring high consistency across multiple samples. For example, in October 2024, Twist Bioscience Corporation, a US-based biotechnology company, introduced FlexPrep, an ultra-high throughput library preparation kit for population genomics. The kit uses a unique Normalization by Ligation (NBL) technology, which improves traditional enzymatic fragmentation methods. This technology removes the need for labor-intensive sample quantification and enables early pooling and multiplexing of samples, making it easier to handle samples of varying amounts. The result is enhanced workflow efficiency and reduced per-sample costs for large-scale next-generation sequencing (NGS) projects. FlexPrep also incorporates a proprietary Twist enzyme that supports high-throughput processing at lower costs, promoting the adoption of NGS in population genomics.

In August 2024, Hitachi High-Tech Corporation, a Japanese manufacturer of electronic and electrical systems, acquired Nabsys, a US-based company specializing in population genomics. The acquisition is aimed at accelerating the adoption of Nabsys' OhmX technology, which is expected to advance research in diagnostics, prognostics, and therapeutics. The move will strengthen Hitachi’s molecular diagnostics business, particularly in the fields of cancer and rare disease research.

Major players in the population genomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Labcorp Holdings Inc., Regeneron Pharmaceuticals Inc., Eurofins Scientific SE, Illumina Inc., Charles River Laboratories, Bio-Rad Laboratories Inc., QIAGEN N.V., Myriad Genetics Inc., Takara Bio Inc, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Color Genomics Inc., Helix OpCo LLC, Personalis Inc., Centogene N.V., Genomics England Limited, Veritas Genetics Inc., Genuity Science, Gene by Gene Ltd., Nebula Genomics Inc., Ancestry.com LLC.

North America was the largest region in the population genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in population genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the population genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Population genomics is the field that studies the genetic differences and similarities across entire populations of organisms by analyzing their complete genomes. It explores how factors such as evolution, natural selection, migration, and genetic drift shape the genetic composition of populations over time.

The primary product services of population genomics include consumables, instruments, services, and software. Consumables consist of single use laboratory materials such as reagents, test kits, assay plates, pipette tips, and cartridges that are essential for performing experiments. It is applied to various sample types, including human, animal, plant, and microbial, and is used in areas such as pharmacogenomics, disease research, ancestry and evolution, personalized medicine, and others. It serves multiple end users, including academic and research institutes, pharmaceutical and biotechnology companies, hospitals and clinics, and others.

The population genomics market research report is one of a series of new reports that provides population genomics market statistics, including population genomics industry global market size, regional shares, competitors with a population genomics market share, detailed population genomics market segments, market trends and opportunities, and any further data you may need to thrive in the population genomics industry. This population genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The population genomics market consists of revenues earned by entities by providing services such as whole genome sequencing, population structure analysis, evolutionary analysis, and variant annotation. The market value includes the value of related goods sold by the service provider or included within the service offering. The population genomics market also includes sales of next-generation sequencers, microarray scanners, imaging systems, and SNP analysis instruments. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.